BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt/β-catenin signalling
Hanmei Bao(Tianjin Medical University Cancer Institute and Hospital), Yan Zhao(Hebei Medical University)
Cited by 32
Related Papers
Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways
|Frontiers in Pharmacology|2021|17